Dinawanao, Marjurie S.

HRN: 04-35-66  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/06/2025
08/13/2025
IV
1.6g
Q6hours
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines